Insight Wealth Partners’s AbbVie ABBV Stock Holding History

Insight Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$541K	Sell	2,489 -224	-8%	-$49.7K	0.08%	79
2025 Q4	$620K	Sell	2,713 -493	-15%	-$112K	0.09%	72
2025 Q3	$742K	Sell	3,206 -5	-0.2%	-$1.02K	0.23%	65
2025 Q2	$596K	Sell	3,211 -304	-9%	-$56.5K	0.23%	64
2025 Q1	$736K	Sell	3,515 -344	-9%	-$66.9K	0.12%	57
2024 Q4	$686K	Buy	3,859 +5	+0.1%	+$919	0.09%	57
2024 Q3	$761K	Buy	3,854 +4	+0.1%	+$747	0.15%	52
2024 Q2	$660K	Hold	3,850	–	–	0.11%	52
2024 Q1	$701K	Sell	3,850 -900	-19%	-$155K	0.12%	46
2023 Q4	$736K	Hold	4,750	–	–	0.13%	44
2023 Q3	$708K	Sell	4,750 -412	-8%	-$60.5K	0.14%	43
2023 Q2	$695K	Sell	5,162 -600	-10%	-$88K	0.16%	44
2023 Q1	$918K	Buy	+5,762	New	+$881K	0.21%	28

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Insight Wealth Partners's ABBV Position: Q1 2026 in Review

Insight Wealth Partners reduced its AbbVie (ABBV) stake by 8.3% in Q1 2026, selling an estimated $49.7K and leaving 2,489 shares worth $541K. The position accounts for 0.08% of the portfolio, ranked #79.

Insight Wealth Partners first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $918K in Q1 2023. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Insight Wealth Partners held 2,489 shares of AbbVie worth $541K as of Q1 2026.
Insight Wealth Partners sold 224 AbbVie shares in Q1 2026, an estimated $49.7K.
AbbVie made up 0.08% of Insight Wealth Partners's portfolio in Q1 2026, its #79 holding.
Insight Wealth Partners first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Insight Wealth Partners's AbbVie position peaked at $918K in Q1 2023.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Insight Wealth Partners's 13F filing for Q1 2026, filed 14 May 2026.